Physician profile
Michael Rosenberg
NPI 1356385330
$111,360.71
in general payments reported to CMS, 2019-2025
41 companies · $3,113 in 2025
The $3,113 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $20K · 2021: $18K · 2022: $21K · 2023: $5,300 · 2024: $2,273 · 2025: $3,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,438 · Travel and Lodging: $2,745 · Consulting Fee: $1,171 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,438.10 |
| Travel and Lodging | $2,744.58 |
| Consulting Fee | $1,171.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $87,562.80 | 2019-2024 | Xarelto |
| Regeneron Pharmaceuticals, INC. | $8,977.45 | 2019 | |
| Penumbra, INC. | $2,153.18 | 2023 | Indigo System |
| Pfizer INC. | $2,150.98 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,022.07 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Novartis Pharmaceuticals Corporation | $924.18 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $902.65 | 2022-2025 | Camzyos, Eliquis |
| Biotronik INC. | $856.12 | 2022-2025 | Orsiro Mission, Recross, Pk Papyrus |
| Angiodynamics, INC. | $851.89 | 2021-2022 | |
| Inari Medical, INC. | $816.89 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $752.11 | 2021-2025 | 2nd Gen Centrimag Primary Console, Mitraclip, Cardiomems |
| Recor Medical INC | $678.11 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Becton, Dickinson and Company | $414.17 | 2024-2025 | Rotarexs 6 F X 135 Cm |
| Ge Healthcare | $398.00 | 2025 | |
| Zoll Medical Corporation | $380.00 | 2024 | Defibrillator |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.79 | 2019-2025 | Lifevest |
| Amgen INC. | $256.07 | 2024-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $231.89 | 2019-2024 | Watchman Access System, Rotapro, Watchman Flx |
| Heartflow, INC. | $226.06 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $225.68 | 2025 | |
| Novo Nordisk INC | $201.09 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Shockwave Medical, INC | $149.38 | 2021 | |
| Abiomed | $123.08 | 2020-2025 | Impella |
| Cook Medical LLC | $118.55 | 2019-2023 | Cook Celect |
| Actelion Pharmaceuticals US, INC. | $99.03 | 2023 | Uptravi, Opsumit |
| Lexicon Pharmaceuticals, INC. | $98.92 | 2023-2024 | Inpefa |
| Janssen Scientific Affairs, LLC | $73.44 | 2019-2022 | |
| Chiesi USA, INC. | $58.46 | 2019-2024 | Kengreal, Cleviprex |
| Cardiovascular Systems INC. | $55.76 | 2022 | |
| Merck Sharp & Dohme LLC | $54.30 | 2025 | Verquvo |
| Bard Peripheral Vascular, INC. | $50.98 | 2024-2025 | Lifestream, True Flow, Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $47.01 | 2023-2025 | Symplicity G3 |
| Alnylam Pharmaceuticals INC. | $34.62 | 2025 | Amvuttra |
| Philips North America LLC | $33.35 | 2023 | |
| Veryan Medical Incorporated | $24.08 | 2023 | Biomimics 3d Vascular Stent System |
| Kestra Medical Technology Services, INC. | $21.33 | 2023 | Assure Wcd |
| Csl Behring | $20.89 | 2019 | |
| Livanova USA, INC. | $20.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.70 | 2023 | Jardiance |
| Corcept Therapeutics | $16.41 | 2024 | Korlym |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.